19 Live Notices for حلول الحقن المناقصات
Showing 1 to 19
Procurement of (Injections) to treat allergies due to the need of all hospitals
04 Jul 2024
07 Aug 2024Human Albumin
1] Procurement of Drugs used in Management of Endocrine Disorders 2] Procurement of Intravenous Fluids and Cough Preparations for Adults
Procurement of Anesthesia and intensive care consumables for the needs of anesthesia and intensive care departments in hospitals
Aseptically Prepared Products
Procurement of Anticoagulant medications (injections) for the needs of all hospitals
Medicines: Injectable Solutions - Cpv: 33692500-2; Drugs For Genito-Urinary System And Hormones - Cpv: 33640000-8; Infusion Solutions - Cpv: 33692400-1 ; Vaccines - Cpv: 33651600-4 ; Heparin - Cpv: 33141550-0 ; Drugs For The Blood, For The Hematopoietic Organs And The Cardiovascular System - Cpv 3362000-2
Rfi - 709154452-1 Manufacture And Supply Of A Tranexamic Acid (Txa) Auto-Injector (Ai)
Procurement of (Injections) to treat patients with acquired immunodeficiency due to the need of a communicable diseases hospital
Procurement of (Injections) to treat patients with acquired immunodeficiency virus for the need of a communicable diseases hospital
* Price Registration * * Electronic Bidding * Acquisitions Of Injectable Medicines, Ophthalmic Solutions
Medicines - Injectable Solutions; 52 Lots;
Request For Offer For Any Awarding Pursuant To Art. 50, Paragraph 1, Lett. B) Of Legislative Decree 31 March 2023 N. 36 And S.M.I. For The Supply Of Radiopharage Drugs Iobenguano 185 Mbq 5 Mci And 370 Mbq 10 Mci Injectable Solutions 10 Ml Bottles And Sodium Iodide (131I) 15 Mci 555 Mbq Capsules
Essential Medical Commodities For Kit Packing, And Unicef Warehouse Replenishment. Open New Window
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V To Ws Allergen Extract Various Origin Excl. Injection Suspensions For Subk. Application F.d. E.g. 11/01/22 - 10/31/24
Conclusion Of Non-exclusive Discount Agreements In Accordance With §§ 130a Para. 8/130c Abs. 1 Sgb V On Drugs With The Active Ingredient Imiquimod (d06bb10) As Part Of A So-called Open-house Model.
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Substance Tapentadol, Atc N02ax06 For The Period 01.11.2022 - 31.10.2024
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Pirfenidone, Atc L04ax05 For The Period 11/01/2022 - 10/31/2024
Procurement Of Some Essential Drug Items, Amoxicillin Cap I.p 500 Mg, Meropenam Inj. 125mg/ Vial.
Tenders by Country